4Angel Vila-Corcolesa,Olga Ochoa-Gondara,Teresa Rodriguez-Blanco, et al. Epidemiology of community-acquired pneumonia in older adults: A population-based study[J]. Respiratory Medicine,2009,103: 309-316.
5Xin Ye,Ph D,Vanja Sikirica,et health care utilization and al. Treatment failure rates and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting:a retrospective claims database analysis[J]. Clinical Therapeutic, 2008,30(2) : 358-371.
6Andrew F, Short NZ, Jim X, et al. A Multicenter,randomized, double-blind,retrospective comparison of 5-and 10-day regimens of levofloxacin in a subgroup of patients aged >65 years with community-acquired pneumonia[J]. Clinical Therapeutics, 2005,27 ( 8 ) : 1251-1258.
7[1]Gaydos CA,Quinn TC ,Eiden JJ.Identification of Chlamydia pneumoniae by DNA amplification of the 16SrRNA gene[J]. J Clin Microbiol, 1992, 30:796-800
8[2]Ieven M,Ursi D, van Bever H, et al.Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M.pneumoniae in acute respiratory tract infections in pediatric patients[J]. J Infect Dis,1996, 173:1445-1452
9[3]Darelid J,Lofgren S,Malmvall BE,et al.Legionella pneumophila serogroup 1 antibody kinetics in patients with Legionnaires' disease:implications for serological diagnosis[J]. Scand J Infect Dis, 2003, 35:15-20
10[4]Jokinen C, Heiskanen L, Juvonen H,et al.Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland[J]. Clin Infect Dis, 2001, 32:1141-1154
